Which design is most efficient for studying rare diseases with exposure data?

Which design is most efficient for studying rare diseases with exposure data?

• A. Cohort study
• B. Case-control study
• C. Cross-sectional study
• D. Randomized controlled trial

Answer: (B)

Studying rare diseases with exposure data is most efficient when you start with people who have the disease and compare them to similar people who do not. In a case-control approach, you identify cases and controls and then look back to see who was exposed to potential risk factors. This is far more feasible than following a large group over time to see who develops a rare disease, which would require enormous resources just to accrue enough cases. The case-control setup lets you study multiple exposures from a relatively small sample, and the association is typically expressed as an odds ratio, which provides a good estimate of the relative risk when the outcome is rare. While there are potential biases to manage, the design’s efficiency and practicality for rare outcomes explain why it’s the best choice in this scenario.

Studying rare diseases with exposure data is most efficient when you start with people who have the disease and compare them to similar people who do not. In a case-control approach, you identify cases and controls and then look back to see who was exposed to potential risk factors. This is far more feasible than following a large group over time to see who develops a rare disease, which would require enormous resources just to accrue enough cases. The case-control setup lets you study multiple exposures from a relatively small sample, and the association is typically expressed as an odds ratio, which provides a good estimate of the relative risk when the outcome is rare. While there are potential biases to manage, the design’s efficiency and practicality for rare outcomes explain why it’s the best choice in this scenario.